The Vax Is Painless And Targets The New Covid Varieties

The vax is painless and targets the new Covid varieties

London, December 14, 2014 : .A group of scientists has begun the testing of a Covid-19 vaccine without needles that will protect against new strains of the virus.
According to the BBC, DIOS-CoVax, a vaccine administered by a jet through air, uses a different technology to combat the disease.This could offer greater protection against Covid variants.

 The Vax Is Painless And Targets The New Covid Varieties-TeluguStop.com

Participants will be between 18- and 50 years old.They will participate in trials at the NIHR Southampton Clinical Research Facility.

Jonathan Heeney, Chief Executive at DIOSynVax (the maker of the vaccine), was quoted saying that “As new varieties emerge, and immunity begins to decline, we require new technologies.”

It is vital to continue developing new vaccine candidates in order to keep ourselves safe from future virus threats.Heeney stated that this is the first step in developing a universal coronavirus vaccine, which will protect us from not only Covid-19 but also future coronaviruses.

While current Covid-19 vaccines use genes taken from the virus spike protein to encode antigens, which causes the immune system to produce antibodies, the new vaccine uses predictive methods to mimic the wider family of coronavirus antigens that researchers hope will give more protection.

The new vaccine is a spring-powered jet injection that delivers it into the skin, offering an alternative to those who have a fear of needle-based injections.

“This isn’t simply ‘yet another’ coronavirus vaccine, as it has both Covid-19 variants and future coronaviruses in its sights,” Saul Faust, director at the NIHR Southampton Clinical Research Facility, was quoted as saying.

“This technology could give wide-ranging protection to huge number of people worldwide,” Faust added.


rvt/arm

#painless #targets #Covid #London #Coronavirus #Covid-19

Disclaimer : TeluguStop.com Editorial Team not involved in creation of this article & holds no responsibility for its content..This Article is Provided by IANS, Please contact IANS if any issues in Article .


Follow Us on FacebookFollow Us on WhatsAppFollow Us on Twitter